The purchase of 7,661 shares by Chemours Company's CEO Mark Newman at an average price of $34.63 per share indicates his confidence in the company's future prospects. This insider trading activity can be seen as a positive signal for investors, as it suggests that the CEO believes the stock is undervalued or has growth potential. As a result, this news may have a positive short-term impact on the stock price.